DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

8.17 0.18 (2.25%)

REAL-TIME: Last trade at

Extended Hours: $8.13 -$0.04 (-0.49%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

PACB $8.17 2.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.98
Previous Close $7.99
Daily Range $7.87 - $8.20
52-Week Range $3.87 - $8.78
Market Cap $583.0M
P/E Ratio -8.59
Dividend (Yield) $0.00 (0.0%)
Volume 440,163
Average Daily Volume 610,677
Current FY EPS -$0.94





Pacific Biosciences of California (PACB) Description

Pacific Biosciences is a leader in the latest generation of human DNA sequencing. Website:

News & Commentary

5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing

A full human genome can now be sequenced for $1,000. That's still a little pricey for mass adoption, but Illumina and Pacific Biosciences could bring the cost down even further -- opening up the genomics floodgates.

Pacific Biosciences Of California (PACB) Flagged As Strong On High Volume

Why Pacific Biosciences of California Stock Skyrocketed 34% in October

PacBio was among the best performing healthcare stocks in October. Find out what lit a fire under its shares.

5 Red-Hot Biotech Stocks to Buy

Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape

Quality Systems Misses on Q2 Fiscal Earnings by a Penny - Analyst Blog

Edwards Lifesciences Tops Q3 Earnings, Revenues; Ups View - Analyst Blog

Strong On High Volume: Pacific Biosciences Of California (PACB)

Pacific Biosciences of California Earnings Rocket Higher on Roche Deal

What investors need to know about Pacific Biosciences' third quarter performance.

Pacific Biosciences of California's (PACB) CEO Michael Hunkapiller on Q3 2014 Results - Earnings Cal

Pacific Biosciences of California's (PACB) CEO Michael Hunkapiller on Q3 2014 Results - Earnings Call Transcript

See More PACB News...

PACB's Top Competitors

PACB $8.17 (2.25%)
Current stock: PACB
TMO $127.96 (2.91%)
Current stock: TMO
ILMN $200.00 (1.08%)
Current stock: ILMN
WAT $120.62 (1.40%)
Current stock: WAT